Vagus Nerve Stimulation in Fibromyalgia - Trial NCT06237595
Access comprehensive clinical trial information for NCT06237595 through Pure Global AI's free database. This phase not specified trial is sponsored by Kasr El Aini Hospital and is currently Recruiting. The study focuses on Fibromyalgia. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Kasr El Aini Hospital
Timeline & Enrollment
N/A
Sep 30, 2023
Feb 28, 2025
Primary Outcome
Visual analogue scale 0-10,Symptom severity scale score,Widespread pain index,Fibromyalgia severity scale
Summary
Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve
 sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to
 evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to
 conventional medical treatment in Egyptian fibromyalgia patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06237595
Device Trial